The pandemic caused public health agencies and life sciences companies to scramble to find effective treatments. Exploring the efficacy of existing drugs to treat COVID, an example of what's known as drug repurposing, was an intense focus for Qais Hatim, a Data Scientist at the US Food and Drug Administration